Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Ramnicu Valcea – page 3

40 clinical trials in Ramnicu Valcea, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Ramnicu Valcea at a glance
40
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

40 trials in Ramnicu Valcea

Open in trial search

Systemic scleroderma

Not recruiting

Study on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years
  • Substances:BI 685509
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.

Atrial fibrillation

Not recruiting

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:RomaniaRomania
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Arteriosclerosis

Not recruiting

Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Asthma

Not recruiting

Study on the Long-term Effects of Dupilumab in Preventing Lung Function Decline in Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Dry eye+1

Not recruiting

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Ianalumab
  • Sponsor:Novartis Pharma AG

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Study on the Effectiveness and Safety of Afimetoran for Patients with Active Lupus

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Afimetoran Besilate Dihydrate
  • Sponsor:Beeline Medicines Corp.

Other cities in Romania

The busiest research cities in the country

All 63 cities in Romania

Clinical research in Ramnicu Valcea

What the registry says about research in the country

01 Autoimmune Disorders

Innovative research focusing on Systemic Lupus Erythematosus (SLE) treatments, evaluating multiple novel therapeutic compounds including cenerimod and deucravacitinib for reducing disease activity and improving long-term patient outcomes.

  • SLE Management Studies
  • Long-term Safety Evaluations
  • Disease Activity Monitoring

Clinical investigations aim to establish new treatment standards for patients with moderate to severe disease manifestations.

02 Rheumatic Conditions

Comprehensive studies examining treatments for Psoriatic Arthritis and Juvenile Psoriatic Arthritis, including new biological therapies and innovative compounds for both adult and pediatric populations.

  • Adult PsA Treatment Studies
  • Pediatric Arthritis Research
  • Biologic Therapy Evaluation

Research focuses on reducing symptoms and improving quality of life across different age groups.

03 Inflammatory Disorders

Ground-breaking research into Sjögren's Syndrome and dermatomyositis, testing novel therapeutic approaches including sibeprenlimab and ianalumab for symptom management and disease control.

  • Inflammatory Disease Markers
  • Novel Treatment Approaches
  • Symptom Management Studies

Studies aim to advance understanding of inflammatory condition treatments and their long-term effectiveness.

04 Musculoskeletal Conditions

Advanced research examining osteoarthritis and axial spondyloarthritis, including innovative pain management solutions and disease-modifying treatments.

  • Pain Management Protocols
  • Joint Function Studies
  • Treatment Safety Assessments

Investigations focus on improving mobility and reducing pain in chronic musculoskeletal conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.